ArticleScientific reports2019
Independent Multi-states of Photo-responsive Polymer/Quantum Dot Nanocomposite Induced via Different Wavelengths of Light.
Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Stimuli-responsive systems are attractive since their properties can be controlled by external stimuli and/or surrounding environment. Recently, more than one stimulus is utilized in order to enhance the performance of systems, or to bypass undesired effects. However, most of previous research on multi-stimuli has been focused on enhancing or inducing changes in one type of response. Herein, we developed a nanocomposite material with independent multi-states composed of photo-responsive polymer and quantum dots (QDs), in which its properties can independently be controlled by different wavelengths of light. More specifically, azobenzene-incorporated poly(dimethylsiloxane) (AzoPDMS) triggers photobending (PB) by 365 nm light and uniformly dispersed methylammonium lead bromide perovskite (MAPbBr
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.